As demonstrated in Additional file 1: Table S2 and Additional file 1: Table S3, higher serum parathyroid hormone (PTH) levels were shown in HD patients with atherogenic dyslipidemia compared with PTH concentrations in HD subjects without this type of dyslipidemia, however, only at the borderline level of significance (P = 0.067). Here, PTH is linked to Huntington disease.